PROTEOLOGICS - Tel Aviv Stock Exchang
PROTEOLOGICS - Tel Aviv Stock Exchang operates in Real Estate Development.
PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) - Total Assets
Latest total assets as of June 2018: ILA19.50 Million ILA
Based on the latest financial reports, PROTEOLOGICS - Tel Aviv Stock Exchang (PRTL) holds total assets worth ILA19.50 Million ILA as of June 2018.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PROTEOLOGICS - Tel Aviv Stock Exchang - Total Assets Trend (2009–2017)
This chart illustrates how PROTEOLOGICS - Tel Aviv Stock Exchang’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PROTEOLOGICS - Tel Aviv Stock Exchang - Asset Composition Analysis
Current Asset Composition (December 2017)
PROTEOLOGICS - Tel Aviv Stock Exchang's total assets of ILA19.50 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 8.5% |
| Accounts Receivable | ILA0.00 | 0.0% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2009–2017)
This chart illustrates how PROTEOLOGICS - Tel Aviv Stock Exchang's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PROTEOLOGICS - Tel Aviv Stock Exchang's current assets represent 0.0% of total assets in 2017, unchanged from 0.0% in 2009.
- Cash Position: Cash and equivalents constituted 8.5% of total assets in 2017, down from 72.2% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
PROTEOLOGICS - Tel Aviv Stock Exchang Competitors by Total Assets
Key competitors of PROTEOLOGICS - Tel Aviv Stock Exchang based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
Big Tech 50 R&D-Limited Partnership
TA:BIGT
|
Israel | ILA14.08 Million |
PROTEOLOGICS - Tel Aviv Stock Exchang - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PROTEOLOGICS - Tel Aviv Stock Exchang generates 0.07x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PROTEOLOGICS - Tel Aviv Stock Exchang is currently not profitable relative to its asset base.
PROTEOLOGICS - Tel Aviv Stock Exchang - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | - | - | |
| Quick Ratio | - | - | |
| Cash Ratio | - | - | |
| Working Capital | ILA- | - | - |
PROTEOLOGICS - Tel Aviv Stock Exchang - Advanced Valuation Insights
This section examines the relationship between PROTEOLOGICS - Tel Aviv Stock Exchang's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 0.3% |
| Total Assets | ILA19.59 Million |
| Market Capitalization | $2.12K USD |
Valuation Analysis
Below Book Valuation: The market values PROTEOLOGICS - Tel Aviv Stock Exchang's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: PROTEOLOGICS - Tel Aviv Stock Exchang's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for PROTEOLOGICS - Tel Aviv Stock Exchang (2009–2017)
The table below shows the annual total assets of PROTEOLOGICS - Tel Aviv Stock Exchang from 2009 to 2017.
| Year | Total Assets | Change |
|---|---|---|
| 2017-12-31 | ILA19.59 Million | +0.31% |
| 2016-12-31 | ILA19.53 Million | -1.10% |
| 2015-12-31 | ILA19.75 Million | -7.67% |
| 2014-12-31 | ILA21.39 Million | -11.77% |
| 2013-12-31 | ILA24.24 Million | -32.23% |
| 2012-12-31 | ILA35.77 Million | -29.99% |
| 2011-12-31 | ILA51.09 Million | -19.42% |
| 2010-12-31 | ILA63.41 Million | +534.08% |
| 2009-12-31 | ILA10.00 Million | -- |